KCNJ11 gene homepage

General information
Gene symbol KCNJ11
Gene name potassium inwardly-rectifying channel, subfamily J, member 11
Chromosome 11
Chromosomal band p15.1
Imprinted Unknown
Genomic reference NG_012446.1
Transcript reference NM_000525.3
Associated with diseases MODY-13, NIDDM, Islet cell hyperplasia, Transient neonatal diabetes mellitus 3
Citation reference(s) -
Curators (1) LOVD-team, but with Curator vacancy
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created May 03, 2013

Links to other resources
HGNC 6257
Entrez Gene 3767
PubMed articles KCNJ11
OMIM - Gene 600937
OMIM - Diseases MODY-13 (diabetes of the young, maturity-onset, type 13 (MODY-13))
NIDDM (diabetes mellitus, noninsulin-dependent (NIDDM))
Islet cell hyperplasia
Transient neonatal diabetes mellitus 3

Active transcripts




NCBI ID     

NCBI Protein ID     

00010380 11 transcript variant 1 NM_000525.3 NP_000516.3 0

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2017. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.